HCM FY 2020 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$228M+11.3% YoY

Gross Profit

$39M17.3% margin

Operating Income

-$199M-87.1% margin

Net Income

-$126M-55.2% margin

EPS (Diluted)

$-0.90

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$82M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$724M

Total Liabilities

$205M

Stockholders' Equity

$484M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$228M	$205M	+11.3%
Gross Profit	$39M	$45M	-11.8%
Operating Income	-$199M	-$145M	-37.0%
Net Income	-$126M	-$104M	-21.3%